Guidelines Development Group

The objective of the Guidelines Development Group (GDG) is to develop evidence-based European Guidelines for breast cancer screening and diagnosis (the European Breast Guidelines) for screening and diagnosis.

The GDG will follow the GRADE approach in defining the healthcare question of interest (population of interest, interventions to be compared and patient-relevant outcomes- PICO), synthesizing the evidence and developing the recommendations for the Guidelines. This will be carried out within virtual working environments and in meetings organised every three months. The initial draft documents and the final versions before publication are subject of open calls for feedback launched online.

The members are also invited to contribute to the other ECIBC objectives, the Digital Mammography Training Template and the European Guidelines Platform covering all processes of care (from screening to end-of-life care). 

An external contractor, CCIb –Iberoamerican Cochrane Centre, supports the GDG for their tasks from literature review to drafting of recommendations.

Members and external experts

Xavier Castells

Xavier Castells

Xavier Castells, MD and PhD, is Professor of the Public Health Department at the UAB (University Autonoma of Barcelona). The large part of his professional career has been dedicated to Cancer Screening. As Chief of the Epidemiology Department of the Hospital del Mar Medical Research Institute (IMIM) has been coordinating the Breast and Colon Cancer Screening Program of some areas in Barcelona.  He has been Chairman of the Advisory Committee on Cancer Screening, of the Catalan Government, since 2006.This Committee proposes the new guidelines and assessments for cancer screening programs in Catalonia.

He has published several papers in the field of breast cancer screening as a result of their participation in different research projects. These projects have been focused on analysing the balance between benefit and harms of cancer screening. More specifically, about the evaluation of false positives. Currently he is leading research projects to assess the association between a previous benign lesions and cancer detection in a cohort of women from a population based breast cancer screening program.

Declaration of interests